Pledpharma: Interview with Nicklas Westerholm and Peder Walberg (video)
Research Interview
2020-10-05
15:25
Redeye met with Nicklas Westerholm, CEO of Pledpharma, and Peder Walberg, CEO of Rare Thyroid Therapeutics, to discuss the two companies’ announced combination and focus on Orphan indications.
NE
Niklas Elmhammer
Disclosures and disclaimers